Interim FDG-PET Does Not Predict Outcome in Advanced-Stage Hodgkin Lymphoma Patients Treated With BEACOPP

British Journal of Haematology - United Kingdom
doi 10.1111/bjh.15602
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Interim FDG-PET Has No Value in Selecting Patients Who Require Treatment Modification in Both Early- And Advanced-Stage Hodgkin Lymphoma

British Journal of Haematology
Hematology
2017English

A Gene Expression-Based Score to Predict Interim Pet Positivity in Hodgkin Lymphoma Patients Treated With Abvd

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

The 23-Gene Gene Expression-Based Assay Does Not Predict Interim Pet Scan Results After Abvd in Advanced Stage Classical Hodgkin Lymphoma in the Us Intergroup S0816 Trial

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Interim FDG-PET/CT in Hodgkin Lymphoma: What Are We Actually Looking At?

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2018English

Interim FDG-PET Has No Value in Selecting Patients Who Require Treatment Modification in Both Early- And Advanced-Stage Hodgkin Lymphoma: Response to Adams and Kwee

British Journal of Haematology
Hematology
2017English

PET-guided Treatment in Advanced-Stage Hodgkin Lymphoma: Yes but Which One?

Oncotarget
Oncology
2019English

Hodgkin Lymphoma: Is There Really a Need for Interim and End-Of-Treatment FDG-PET Evaluations?

British Journal of Haematology
Hematology
2016English

Ebeacopp With or Without Rituximab in Interim-Pet-Positive Advanced-Stage Hodgkin Lymphoma: Updated Results of the International, Randomized Phase 3 GHSG Hd18 Trial

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Predictive Value of FDG-PET in Patients With Advanced Medullary Thyroid Carcinoma Treated With Vandetanib

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy